VMD - Strong Execution By Insider-Owners Ensures Viemed's Growth

• Respiratory disease management contributes to growing healthcare costs in developed societies with aging demographics. There is a pressing need for Governments to reduce such healthcare costs.
• With 44% CAGR in revenue growth since 2010, Viemed exhibited strong fundamentals in addressing this healthcare need.
• Strong management track record and 13% insider ownership ensure that shareholders’ interests are well aligned, with management having an owner’s mentality.
• The key risk to Viemed is regulatory intervention in pricing.

For further details see: